Patents by Inventor James Moser
James Moser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10385412Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base.” fu addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: GrantFiled: December 21, 2016Date of Patent: August 20, 2019Assignee: LUMINEX CORPORATIONInventor: Michael James Moser
-
Publication number: 20170114421Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base.” fu addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: ApplicationFiled: December 21, 2016Publication date: April 27, 2017Applicant: LUMINEX CORPORATIONInventor: Michael James MOSER
-
Patent number: 9562261Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: GrantFiled: December 10, 2014Date of Patent: February 7, 2017Assignee: LUMINEX CORPORATIONInventor: Michael James Moser
-
Publication number: 20150159206Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: ApplicationFiled: December 10, 2014Publication date: June 11, 2015Inventor: Michael James MOSER
-
Patent number: 8936913Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: GrantFiled: September 26, 2012Date of Patent: January 20, 2015Assignee: Luminex CorporationInventor: Michael James Moser
-
Publication number: 20130040287Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: ApplicationFiled: September 26, 2012Publication date: February 14, 2013Inventor: Michael James Moser
-
Patent number: 8313932Abstract: The present invention provides nucleic acid based polymerase inhibitors and methods for reducing non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors provide a double stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but is incapable of being extended by the polymerase enzyme. The polymerase binds to the polymerase inhibitor which sequesters the enzyme until the temperature achieves a level that denatures the double stranded portion of the inhibitor after which the polymerase is released and can then catalyze nucleic acid extension.Type: GrantFiled: September 17, 2010Date of Patent: November 20, 2012Assignee: Luminex CorporationInventors: Michael James Moser, David J. Marshall, James R. Prudent, Cristopher V. Van Hout, Christine A. Larsen
-
Patent number: 8293472Abstract: Disclosed are methods for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: GrantFiled: June 6, 2006Date of Patent: October 23, 2012Assignee: Luminex CorporationInventor: Michael James Moser
-
Publication number: 20120122095Abstract: Disclosed are methods and kits for identifying a virulent bacteria in a sample, which may include virulent bacteria belonging to the Bacillus genus (e.g., Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis). Typically, the methods include (a) reacting a mixture that includes, in addition to nucleic acid isolated from the sample, (i) at least one oligonucleotide capable of specifically hybridizing to nucleic acid of plasmid pX01; and (ii) at least one oligonucleotide capable of specifically hybridizing to nucleic acid of plasmid pX02. In addition, the mixture may include control nucleic acid. In the methods, nucleic acid of plasmid pX01 and nucleic acid of plasmid pX02 are detected, and optionally control nucleic acid is detected, thereby identifying the virulent bacteria.Type: ApplicationFiled: January 11, 2007Publication date: May 17, 2012Inventors: Michael James Moser, David J. Marshall
-
Patent number: 8107256Abstract: A networking appliance includes a chassis, an off-the-shelf motherboard mounted on said chassis, said motherboard including at least one expansion bus, one or more separately removable expansion module mounted on said chassis, and a number of card slots in the expansion module for accommodating expansion cards. A connection arrangement provides a signal connection between the card slots in the expansion modules and the expansion buses.Type: GrantFiled: October 26, 2007Date of Patent: January 31, 2012Assignee: Solace Systems, Inc.Inventors: Paul Kondrat, James Moser, Scott Drennan, Jonathan Bosloy, Charles Mitchell, Shawn McAllister
-
Publication number: 20110104678Abstract: The present invention provides nucleic acid based polymerase inhibitors and methods for reducing non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors provide a double stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but is incapable of being extended by the polymerase enzyme. The polymerase binds to the polymerase inhibitor which sequesters the enzyme until the temperature achieves a level that denatures the double stranded portion of the inhibitor after which the polymerase is released and can then catalyze nucleic acid extension.Type: ApplicationFiled: September 17, 2010Publication date: May 5, 2011Inventors: Michael James Moser, David J. Marshall, James R. Prudent, Cristopher V. Van Hout, Christine A. Larsen
-
Patent number: 7820808Abstract: The present invention provides nucleic acid based polymerase inhibitors and methods for reducing non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors provide a double stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but is incapable of being extended by the polymerase enzyme. The polymerase binds to the polymerase inhibitor which sequesters the enzyme until the temperature achieves a level that denatures the double stranded portion of the inhibitor after which the polymerase is released and can then catalyze nucleic acid extension.Type: GrantFiled: April 1, 2004Date of Patent: October 26, 2010Assignee: EraGen Biosciences, Inc.Inventors: Michael James Moser, David J. Marshall, James R. Prudent, Christopher V. Van Hout, Christine A. Larsen
-
Publication number: 20100221702Abstract: Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base. In addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.Type: ApplicationFiled: June 6, 2006Publication date: September 2, 2010Inventor: Michael James Moser
-
Patent number: 7703864Abstract: A rectilinear folded and glued container with tiered shelves has multiple shelf panels cut out of a front panel with which the shelf panels, and main container front, side and back panels are integrally connected. The container has an internally placed shelf-raising panel that is attached to the shelf panels as part of a fold and glue processing technique that produces a knocked down flat container to be erected. The shelf raising panel preferably is an integral panel that is separate from the main container panels so as to be relatively movable, and is affixed to the shelf panels. Displacing or translating the shelf-raising panel during erection of the container from its knocked-down-flat configuration articulates the shelves into position. The shelf raising panel can be captured between top and bottom ends of the erected container, thus fixing the erected container and articulated shelves in a rigid shape.Type: GrantFiled: January 16, 2007Date of Patent: April 27, 2010Assignee: McLean Packaging CorporationInventor: James Moser
-
Patent number: 7515784Abstract: A field reconfigurable muxponder for use in an optical transport system. The muxponder includes one or more tributary cards, where each tributary card is adapted to receive an optical data signal and conditions the optical data signal into an intermediate data signal constituted in accordance with a tributary interface format. In this way, the muxponder is able to aggregate optical data signals having different protocols and/or different data rates. The muxponder further includes a chassis that is adapted to receive a predefined number of tributary cards and outputs an optical system signal independently from the availability of the optical data signals from the tributary cards. The tributary cards and the chassis integrally form one line card.Type: GrantFiled: April 20, 2005Date of Patent: April 7, 2009Assignee: Altera CorporationInventors: Ketan Bhalla, Andre Lortie, Kyle Edginton, James Moser, Gamal Refai-Ahmed, Marc Nadeau, Ross Saunders, Lee Shyue Choong
-
Publication number: 20080169339Abstract: A rectilinear folded and glued container with tiered shelves has multiple shelf panels cut out of a front panel with which the shelf panels, and main container front, side and back panels are integrally connected. The container has an internally placed shelf-raising panel that is attached to the shelf panels as part of a fold and glue processing technique that produces a knocked down flat container to be erected. The shelf raising panel preferably is an integral panel that is separate from the main container panels so as to be relatively movable, and is affixed to the shelf panels. Displacing or translating the shelf-raising panel during erection of the container from its knocked-down-flat configuration articulates the shelves into position. The shelf raising panel can be captured between top and bottom ends of the erected container, thus fixing the erected container and articulated shelves in a rigid shape.Type: ApplicationFiled: January 16, 2007Publication date: July 17, 2008Inventor: James Moser
-
Publication number: 20080108124Abstract: The present invention provides nucleic acid based polymerase inhibitors and methods for reducing non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors provide a double stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but is incapable of being extended by the polymerase enzyme. The polymerase binds to the polymerase inhibitor which sequesters the enzyme until the temperature achieves a level that denatures the double stranded portion of the inhibitor after which the polymerase is released and can then catalyze nucleic acid extension.Type: ApplicationFiled: April 1, 2004Publication date: May 8, 2008Inventors: Michael James Moser, David J. Marshall, James R. Prudent, Cristopher V. Van Hout, Christine A. Larsen
-
Publication number: 20070022549Abstract: A method and apparatus for cleaning a hearing aid provides a housing having a motor drive and speed control. A rotary chamber is mounted to the housing and driven by the motor drive. A drive shaft can be provided connecting the motor drive and the rotary chamber. The rotary chamber has a wall with at least one receptacle for holding a hearing aid. The rotary chamber can have two openings, one for a hearing aid and a second opening for another hearing aid or a counterweight. The rotary chamber can be counterweighted to compensate for the weight of a single hearing aid or any other arrangements of multiple hearing aids. Each receptacle is configured to hold a hearing aid. The motor drive is powered sufficiently to rotate the hearing aid at the speed of between about 2800 and 3200 rpm in order to generate a G-force on the hearing aid of about 270 G's.Type: ApplicationFiled: June 29, 2006Publication date: February 1, 2007Applicant: GENERAL HEARING INSTRUMENT, INC.Inventors: Gregory Siegle, Roger Juneau, Edward Desporte, Michael Major, Gene Adoue, Sherriel Johnson, James Moser, Brian Tanner
-
Publication number: 20050185961Abstract: A field reconfigurable muxponder for use in an optical transport system. The muxponder includes one or more tributary cards, where each tributary card is adapted to receive an optical data signal and conditions the optical data signal into an intermediate data signal constituted in accordance with a tributary interface format. In this way, the muxponder is able to aggregate optical data signals having different protocols and/or different data rates. The muxponder further includes a chassis that is adapted to receive a predefined number of tributary cards and outputs an optical system signal independently from the availability of the optical data signals from the tributary cards. The tributary cards and the chassis integrally form one line card.Type: ApplicationFiled: April 20, 2005Publication date: August 25, 2005Inventors: Ketan Bhalla, Andre Lortie, Kyle Edginton, James Moser, Gamal Refai-Ahmed, Marc Nadeau, Ross Saunders, Lee Choong
-
Patent number: 6915036Abstract: A field reconfigurable muxponder for use in an optical transport system. The muxponder includes one or more tributary cards, where each tributary card is adapted to receive an optical data signal and conditions the optical data signal into an intermediate data signal constituted in accordance with a tributary interface format. In this way, the muxponder is able to aggregate optical data signals having different protocols and/or different data rates. The muxponder further includes a chassis that is adapted to receive a predefined number of tributary cards and outputs an optical system signal independently from the availability of the optical data signals from the tributary cards. The tributary cards and the chassis integrally form one line card.Type: GrantFiled: October 11, 2002Date of Patent: July 5, 2005Assignee: PTS CorporationInventors: Ketan Bhalla, Andre Lortie, Kyle Edginton, James Moser, Gamal Refai-Ahmed, Marc Nadeau, Ross Saunders, Lee Shyue Choong